1
|
Talebnia F, Pushparajah D, Chandrasekaran S, Hersch SJ, Nafissi N, Slavcev R. Application of an electro elution system for direct purification of linear covalently closed DNA fragments. J Chromatogr B Analyt Technol Biomed Life Sci 2023; 1218:123622. [PMID: 36842293 DOI: 10.1016/j.jchromb.2023.123622] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2022] [Revised: 01/23/2023] [Accepted: 01/25/2023] [Indexed: 02/10/2023]
Abstract
Gene therapy is a powerful treatment modality. Non-viral gene therapy vectors power one arm of this important approach, due to their enhanced safety profile compared to their viral counterparts. New non-viral approaches continue to be developed, but purification can bottleneck the scaleup and cost-effectiveness and quality of some of these advanced vectors. We require more advanced purification and separation techniques compared to conventional methods to maximize resolution in a scalable manner. The Prep Cell system is a continuous electro elution system that contains a circular gel casting tube where DNA mixtures can be run through and subsequently migrate into an elution chamber, to be eluted by a peristaltic pump. This DNA separation and purification process confers advantages over other conventional methods, including i) the elimination of multiple downstream purification process requirements; ii) its ability to be applied in mid-scale settings, and iii), its high-resolution power. In this study, we assessed the ability of this Prep Cell Model 491 system to purify a novel type of non-viral linear covalently closed (LCC) DNA minivector (ministring DNA) from its precursor parent plasmid DNA and process by-product DNA species by analyzing for effective separation via agarose gel electrophoresis, recovery yield, single enzyme digestion, and quality control assessments. Overall, effective separation and resolution of mini-DNA vectors was obtained using the Prep Cell system, conferring its potential to be applied towards mid-scale purification of DNA vectors for a variety of research, and eventually, clinical applications.
Collapse
Affiliation(s)
- F Talebnia
- Mediphage Bioceuticals, Inc. 661 University Avenue, Suite 1300, MaRS West Tower, Toronto, ON M5G0B7, Canada
| | - D Pushparajah
- University of Waterloo, 200 University Avenue West, Waterloo, ON N2L 3G1, Canada
| | - S Chandrasekaran
- Mediphage Bioceuticals, Inc. 661 University Avenue, Suite 1300, MaRS West Tower, Toronto, ON M5G0B7, Canada
| | - S J Hersch
- Mediphage Bioceuticals, Inc. 661 University Avenue, Suite 1300, MaRS West Tower, Toronto, ON M5G0B7, Canada
| | - N Nafissi
- Mediphage Bioceuticals, Inc. 661 University Avenue, Suite 1300, MaRS West Tower, Toronto, ON M5G0B7, Canada.
| | - R Slavcev
- Mediphage Bioceuticals, Inc. 661 University Avenue, Suite 1300, MaRS West Tower, Toronto, ON M5G0B7, Canada; University of Waterloo, 200 University Avenue West, Waterloo, ON N2L 3G1, Canada.
| |
Collapse
|
2
|
Konstantinidis S, Reinhart SR, Castagna C, Poplyk MR, Rustandi RR, Flor KL, Acevedo-Skrip J, Thompson R, Wang CJ, Wang SC, Winters MA. Regeneration of Capto™ Core 700 resin through high throughput and laboratory scale studies and impact on production of a SARS-CoV-2 vaccine candidate. Biotechnol J 2022; 17:e2200191. [PMID: 35771570 PMCID: PMC9353343 DOI: 10.1002/biot.202200191] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2022] [Revised: 06/03/2022] [Accepted: 06/24/2022] [Indexed: 12/05/2022]
Abstract
During the development of a SARS‐CoV‐2 vaccine candidate, at the height of the COVID‐19 pandemic, raw materials shortages, including chromatography resins, necessitated the determination of a cleaning in place (CIP) strategy for a multimodal core‐shell resin both rapidly and efficiently. Here, the deployment of high throughput (HT) techniques to screen CIP conditions for cleaning Capto Core 700 resin exposed to clarified cell culture harvest (CCCH) of a SARS‐CoV‐2 vaccine candidate produced in Vero adherent cell culture are described. The best performing conditions, comprised of 30% n‐propanol and ≥0.75 N NaOH, were deployed in cycling experiments, completed with miniature chromatography columns, to demonstrate their effectiveness. The success of the CIP strategy was ultimately verified at the laboratory scale. Here, its impact was assessed across the entire purification process which also included an ultrafiltration/diafiltration step. It is shown that the implementation of the CIP strategy enabled the re‐use of the Capto Core 700 resin for up to 10 cycles without any negative impact on the purified product. Hence, the strategic combination of HT and laboratory‐scale experiments can lead rapidly to robust CIP procedures, even for a challenging to clean resin, and thus help to overcome supply shortages.
Collapse
Affiliation(s)
| | - Seth R Reinhart
- Vaccine Process Research & Development, Merck & Co., Inc., Rahway, NJ, USA
| | - Christine Castagna
- Vaccine Process Research & Development, Merck & Co., Inc., Rahway, NJ, USA
| | - Murphy R Poplyk
- Vaccine Process Research & Development, Merck & Co., Inc., Rahway, NJ, USA
| | - Richard R Rustandi
- Vaccine Analytical Research & Development, Merck & Co., Inc., Rahway, NJ, USA
| | - Kristen L Flor
- Investigative Pathology, MRL, Merck & Co., Inc., Rahway, NJ, USA
| | | | - Rachel Thompson
- Vaccine Analytical Research & Development, Merck & Co., Inc., Rahway, NJ, USA
| | - Christopher J Wang
- Vaccine Analytical Research & Development, Merck & Co., Inc., Rahway, NJ, USA
| | - Sheng-Ching Wang
- Vaccine Process Research & Development, Merck & Co., Inc., Rahway, NJ, USA
| | - Michael A Winters
- Vaccine Process Research & Development, Merck & Co., Inc., Rahway, NJ, USA
| |
Collapse
|
3
|
Kiesewetter A, Menstell P, Peeck LH, Stein A. Development of pseudo-linear gradient elution for high-throughput resin selectivity screening in RoboColumn ® Format. Biotechnol Prog 2016; 32:1503-1519. [PMID: 27604682 PMCID: PMC6585662 DOI: 10.1002/btpr.2363] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2016] [Revised: 08/29/2016] [Indexed: 11/30/2022]
Abstract
Rapid development of chromatographic processes relies on effective high‐throughput screening (HTS) methods. This article describes the development of pseudo‐linear gradient elution for resin selectivity screening using RoboColumns®. It gives guidelines for the implementation of this HTS method on a Tecan Freedom EVO® robotic platform, addressing fundamental aspects of scale down and liquid handling. The creation of a flexible script for buffer preparation and column operation plus efficient data processing provided the basis for this work. Based on the concept of discretization, linear gradient elution was transformed into multistep gradients. The impact of column size, flow rate, multistep gradient design, and fractionation scheme on separation efficiency was systematically investigated, using a ternary model protein mixture. We identified key parameters and defined optimal settings for effective column performance. For proof of concept, we examined the selectivity of several cation exchange resins using various buffer conditions. The final protocol enabled a clear differentiation of resin selectivity on miniature chromatography column (MCC) scale. Distinct differences in separation behavior of individual resins and the influence of buffer conditions could be demonstrated. Results obtained with the robotic platform were representative and consistent with data generated on a conventional chromatography system. A study on antibody monomer/high molecular weight separation comparing MCC and lab scale under higher loading conditions provided evidence of the applicability of the miniaturized approach to practically relevant feedstocks with challenging separation tasks as well as of the predictive quality for larger scale. A comparison of varying degrees of robotic method complexity with corresponding effort (analysis time and labware consumption) and output quality highlights tradeoffs to select a method appropriate for a given separation challenge or analytical constraints. © 2016 American Institute of Chemical Engineers Biotechnol. Prog., 32:1503–1519, 2016
Collapse
Affiliation(s)
| | | | - Lars H Peeck
- Life Science devision, Merck KGaA, Darmstadt, Germany
| | - Andreas Stein
- Life Science devision, Merck KGaA, Darmstadt, Germany
| |
Collapse
|